Roche Diagnostics DNA-Based Clot Risk Tests Set For Early 2004 Launch
This article was originally published in The Gray Sheet
Executive Summary
Roche plans to develop additional DNA-based tests for inherited disorders using the same platform as its initial assays for genetic clotting risk, the firm says